Southeast Asia Dose Optimization of Tafenoquine

Clinical trial NCT04704999 · RECRUITING

Trial details

NCT number: NCT04704999
Sponsor: University of Oxford
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Plasmodium Vivax Malaria

Start date: 2024-07-22
Primary completion: 2027-10-04
Enrollment: 820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.